Variable | Total cases | Study group (n = 30) | Control group (n = 54) | p value |
---|---|---|---|---|
Operative time, [min, mean ± SD] | 276.62 ± 41.45 | 271.3 ± 24.03 | 279.57 ± 48.47 | 0.299 |
EBL, [mL, median (range)] | 80 (30–300) | 65 (40–300) | 90 (30–300) | 0.352 |
Pathologic T stage, [n (%)] | 0.166 | |||
T1 | 30 (35.71) | 6 (20.00) | 24 (44.44) | |
T2 | 32 (38.10) | 14 (46.67) | 18 (33.33) | |
T3 | 18 (21.43) | 8 (26.67) | 10 (18.52) | |
T4 | 4 (4.76) | 2 (6.67) | 2 (3.70) | |
Pathological lymph node invasion, n (%) | 9 (10.71) | 4 (13.33) | 5 (9.26) | 0.563 |
Postoperative creatinine, [umol/L, median (range)] | 78 (32–179) | 81 (38–158) | 76 (32–179) | 0.501 |